Skip to main content

Table 2 Plasmodium falciparum gametocyte density during follow up

From: Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment

DaysArtemether–lumefantrineDihydroartemisinin–piperaquinep value
Day 01.98 (0.87–5.30)2.66 (0.82–4.15)0.388
Day 71.23 (0.15–2.45)0.92 (0.21–2.85)0.439
Day 140.50 (0.12–1.26)0.65 (0.34–2.28)0.457
Day 210.34 (0.12–0.76)0.72 (0.20–1.94)0.529
Day 280.43 (0.32–1.18)0.53 (0.38–1.84)0.621
Day 420.42 (0.22–1.25)0.37 (0.16–0.42)0.355
  1. Data included: gametocyte positive individuals. Median density on day 7, 14, 28 and 42 is not necessarily assessed over the same individuals used to determine gametocyte density at enrolment
  2. *p-value represents difference between groups. Difference in gametocyte density was tested using the Wilcoxon rank-sum test. Median and IQR